Searched for
CHRYSCAPITAL
SoftBank snags Rs 2,873 crore from Lenskart stake sale, clocking 7x returnSVF II Lightbulb Cayman, a SoftBank affiliate, sold 5.65 crore shares, or 3.25%, in Lenskart for Rs 2,873 crore through a block deal on Wed...- Novartis sharpening India strategy as a pure-play innovatorNovartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...
- Indian IT pack falls; MeitY’s e-gaming rulebookIndian IT stocks suffered on Wednesday after HCLTech’s weak Q4 numbers. This and more in today’s ETtech Top 5.
- India to attract major share of EQT's $15.6-billion Asia fund: EQT India headEQT expects India to remain a top capital destination in its new Asia fund, with roughly one-third allocation historically. The firm sees s...
- Jhunjhunwalas-backed IKS healthcare looks to acquire TruBridge for $600 millionInventurus Knowledge Solutions (IKS), backed by the family of late investor Rakesh Jhunjhunwala, is in advanced talks to acquire Nasdaq-lis...
- ChrysCapital, two others launch open offer for Novartis IndiaA consortium including WaveRise Investments, ChrysCapital, and Two Infinity Partners is set to acquire a significant stake in Novartis Indi...
- ChrysCapital sets sights on pharma buyout dealsChrysCapital, led by MD Kshitij Sheth, aims to acquire Indian companies in the formulation business with potential valuations of $200 milli...
- ChrysCapital raises $700 million to maintain stake in National Stock ExchangeIndian private equity firm ChrysCapital has raised $700 million in new funds, allowing the firm to maintain its stake in India's National S...
- ChrysCapital eyes stake in Delhi's Centre For Sight eye hospitalChrysCapital's proposed investment will give an exit to Mahindra Partners, the PE arm of Mahindra & Mahindra, which owns about 32% stake in...
- ChrysCapital still in race to buy controlling stake in Glenmark Life SciencesPrivate equity firm ChrysCapital remains firmly in the running to buy Glenmark Pharma's stake in Glenmark Life Sciences (GLS) with rival bi...
- ChrysCapital buys ResultsCX from One Equity PartnersResultsCX provides automation-driven customer support, acquisition, enrolment, retention, membership assistance, technical support and tran...
- ChrysCapital set to launch $1.2 billion PE fundChrys Capital IX would be the largest by an India-specific fund manager
- ChrysCapital Buys Minority Stake In Safex Chemicals India for Rs 364 croreThe transaction involved a combination of secondary sale by an existing PE investor, BanyanTree Growth Capital, along with a primary raise ...
- Valued at Rs 750 crore - ChrysCapital set to buy Mufti in Rs 500 crore dealChrysCapital is in exclusive discussions with Credo Brands Marketing, the owner of Mufti, and is completing due diligence ahead of signing ...
- ChrysCapital sells 3% in Intas to Capital InternationalChrysCapital will continue to hold a 3% stake in Intas, making it the longest and probably the most successful private equity investment in...
- PE firm ChrysCapital raises $600 million from several investorsChrysCapital has made 80 investments in India and exited 60 of these since its inception. The fund claims to have realised over $4 billion ...
- ChrysCapital invests $30 million in L&T InfotechChrysCapital's $30-million cheque in the L&T Infotech IPO marks its return to public market investing after big, profitable exits from Info...
- ChrysCapital exits Mankind Pharma with ten-fold gain, offloads stake to CapitalChrysCapital has sold its 11% stake in Mankind Pharma to Capital International for little over $200 million, or Rs 1,300 crore.
- ChrysCapital invests Rs 250 crore in CavinKareFMCG firm CavinKare today said Mauritius-based private equity firm ChrysCapital has invested Rs 250 crore in it for an undisclosed stake
- Ashish Dhawan to step down as ChrysCapital Sr MDChrysCapital, which manages total assets of $2 bn, will also see the exit of Brahmal Vasudevan, one of its managing directors, by year-end.
Load More
